EX-4.11 2 ncna-ex411_322.htm EX-4.11 ncna-ex411_322.htm

[Certain identified information has been excluded from this exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed. “[***]” denotes omissions.]

 

Exhibit 4.11

Amendment No. 4

 

 

This Amendment, effective as of the last signature date below, is made:

 

BETWEEN:

 

(1)

CARDIFF UNIVERSITY, whose administrative offices are at 30-36 Newport Road, Cardiff, CF24 0DE, U.K. (the University);

 

(2)

University College Cardiff Consultants Ltd, a company incorporated under the laws of England and Wales (company number 1477909) whose registered office is at 30-36 Newport Road, Cardiff, United Kingdom, CF24 0DE (“UC3”); and

(3)

NUCANA PLC, a company incorporated under the laws of England and Wales (company number 3308778) whose registered office is at 77 / 78 Cannon Street, London, England, EC4N 6AF (“NuCana”),

 

together the “Parties” and each a “Party”.

 

RECITAL:

 

The Parties entered into a Research, Collaboration and Licence Agreement dated 21 December 2017 for a research project, as amended and supplemented by Amendment No. 1 between the Parties with an effective date of 21 December 2017, Amendment No.2 with an effective date of 20 December 2019, and Amendment No. 3 with an effective date of 31 January 2020 (the “Agreement”).  

 

The Parties have agreed to further extend the Agreement on the terms set forth in this Amendment No.4.

 

IT IS AGREED AS FOLLOWS:

 

1.

Status and Purpose of this Amendment

This Amendment is supplemental to the Agreement. Except as expressly set forth in this Amendment, the Agreement shall remain in full force and effect.

 

2.

Amendments to the Agreement

The Parties agree that, with effect from the date of this Amendment, the terms of the Agreement shall be amended as follows:

 

2.1

Clause 1.3 shall be amended by the addition of the following after sub-clause 1.3.4:

 

“The University agrees to engage the following staff members on the Project during the period from 1 January 2020 to the end of the Project Period:

 

1.3.5[***],

1.3.6[***] (Research Fellow and Joint Principal Investigator)

1.3.7[***] (Research Fellow and Joint Principal Investigator)

1.3.8[***], Grade 4 Technician,”

 

and the foregoing staff members will be deemed to be the “Research Team” during the period from 1 January 2020 to the end of the Project Period.

 

2.3

Clause 1.4 shall be deleted in its entirety and replaced with the following:

 

“1.4 The Project will begin on the Effective Date and continue to 31 December 2020.  NuCana (in its sole discretion) may extend the Project Period to  31 December 2021 by giving the University at least 3 months written notice to be served on or before 30 September 2020 that it is satisfied with the progress of the the Deliverables achieved by the Research Team. The Project

 


 

may be extended beyond 31 December 2021 for a further period or periods by the written agreement of the Parties as to the scope of any additional work and/ or research funding.

 

2.4

Clause 2.1 shall be amended by the addition of the following:

 

 

2.1.5

£[***] on 1 July 2020;

 

2.1.6

£[***] on 1 January 2021;

 

and subject to Nucana electing to extend the Project pursuant to clause 1.4 to 31 December 2021:

 

 

2.1.7

£[***]  on 1 July 2021; and

 

2.1.8

£[***]  on 31 December 2021.”

 

2.5

Amend Clause 17 Definitions by the addition of the following:

 

“Deliverables” means the deliverables set out in Schedule 1.

 

2.6

Amend the definition of “Principal Investigators” in Clause 17 Definitions to remove the reference to [***].

 

2.7

Insert “and the period from 1 January 2020 to 31 December 2020 or if Nucana elects to extend the Project pursuant to clause 1.4 to 31 December 2021, to 31 December 2021” after “Initial Project Period” in the definition of “Project Period” in Clause 17 Definitions.

 

2.7

Schedule One shall be deleted in its entirety and replaced with the following:

 

SCHEDULE ONE

Project

[***]

 

Deliverables

[***]

Nucleoside Families

[***]

 

 

IN WITNESS WHEREOF, the Parties hereto have caused this Amendment to be executed by their authorized officers or representatives on the date indicated below.

 

Signed on behalf of

 

 

 

Cardiff University

[***]

Date

19 February 2020

 

 

 

 

 

 

 

 

Signed on behalf of

 

 

 

University College Cardiff University

 

 

 

Consultants Ltd

[***]

Date

19 February 2020

 

 

 

 

 

 

 

 

Signed on behalf of

/s/Hugh S. Griffith

Date

20 February 2020

NuCana Plc